Friday, January 25, 2008

FDA to review Vytorin cholesterol drug study

U.S. regulators said on Friday they would review a study showing a Merck and Schering-Plough cholesterol drug worked no better than a generic in preventing the build-up of arterial plaque.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)